PeerView
@PeerView
Followers
5K
Following
9K
Media
4K
Statuses
21K
Improving the knowledge, skills, and strategies that support clinical performance and patient outcomes through the provision of live and on-demand CE
New York, NY
Joined June 2009
Watch Dr. Sara A. Hurvitz, Dr. Kamel Abou Hussein, Dr. Carlos H. Barrios & Dr. Eleonora Teplinsky (@drteplinsky) discuss HR+, HER2- breast cancer updates from #SABCS #BreastCancer #MedEd – to participate, visit: https://t.co/X92afawhjQ
0
2
2
Get expert insight on the latest evidence on how patients with neuroendocrine neoplasms may benefit from emerging treatment options with Drs. Simron Singh, Jaume Capdevila, & Diane Reidy-Lagunes. 📅 1/8 at 7:00 PM PST 🔗 https://t.co/jYqaZ1JqeI Produced with @netcanceraware
0
2
2
Join Dr. Susana Banerjee and @DrKatyMoore for a review of the evidence supporting approved and emerging #ADCs in #GynecologicMalignancies and strategies for using these agents in personalized patient care.
0
1
1
Remember to join us tomorrow at 7:00 PM CST, for our #BreastCancer live in-person and virtual symposium. Please tweet your questions in advance and follow @PeerView for more #MedEd content! 🔗 https://t.co/kQe4rHc8Es Presented by: @BCJoyceO, @JavierCortesMD, @LoiblSibylle &
0
4
3
“Targeted Biologic Therapy for Optimal Patient Outcomes in #CRSwNP” with Drs. Peters and Platt #MAAP #Otolaryngology 📅 1/16 at 11:40 AM CST 🔗 https://t.co/HO91o4Kwvj
0
4
4
Gain clarity on using immunotherapy and targeted platforms across the #HCC disease spectrum with Prof Dr Galle and Drs Kelley & El-Khoueiry (@DrElkhoueiry). 1/8 at 7:00 PM PST. Produced with @BlueFaeryLiver #GI26 #oncology 🔗 https://t.co/slzV7WTHgx
0
3
4
Shoutout to @jhaveri_komal, @curijoey, and @elmayermd for delivering an outstanding #SABCS25 program last night packed with practical insights. 📺 Catch the re-broadcast on 12/16 at 12:00 PM EST: https://t.co/TTOn1KoWIY Thanks to @AstraZeneca, @Genentech, @EliLillyandCo and
0
7
10
How might emerging treatments for GBA1 mutation–driven #LysosomalStorageDisorders potentially transform care for patients with these rare diseases? Get expert insights in this @PeerView CME/CE session. 🗓️ 1/15 at 1 PM EST | Virtual Register today: https://t.co/6GSlS45FLx
0
6
7
Remember to join us Thursday, December 11, at 8:00 AM EST, for our #HER2-altered #SolidTumors virtual symposium #ESMOAsia25 #Oncology 🔗 https://t.co/oOoS11NVq8
0
5
7
Watch Dr. Komal Jhaveri (@jhaveri_komal), Prof. Giuseppe Curigliano (@curijoey), & Dr. Erica L. Mayer (@elmayermd) discuss HR+, HER2- MBC updates from #SABCS #BreastCancer #MedEd – to participate, visit: https://t.co/TTOn1Kpuyw
0
3
6
Answer questions on available and emerging biologic agents for #CRSwNP care in this #MedEd activity: https://t.co/mSAud8rQm5
#Otolaryngology
lrn.peerview.com
See a new #CRSwNP activity via @PeerView #MedEd
0
2
3
Cutting-edge AI-driven patient simulations help bring best practices to life for real-world treatment delivery in HR+, HER2- early #BreastCancer with adjuvant CDK4/6i. Erica L. Mayer (@elmayermd) offers expert insight in this new #PeerView activity! 🔗
lrn.peerview.com
See a new #breastcancer activity via @PeerView @elmayermd #CDK4/6i #MedEd
0
1
3
Shoutout to Prof. Eric Van Cutsem, MD, PhD, Jung-Yun Lee, MD, PhD & James Chih-Hsin Yang, MD, PhD for an outstanding #ESMOAsia25 session! 📺 Missed it? Catch the broadcast on 12/11: https://t.co/oOoS11NVq8 Supported by an independent educational grant from @DaiichiSankyo #CME
0
4
7
📢 Attending #SABCS25? Don’t just sit in—get involved. Join @PeerView for THREE dynamic breast cancer events starting tomorrow (12/9–12/11), packed with real-world insights you can put to work right away. 🎗️Seats are limited—grab yours now 👇 🔗
c.peerview.com
Exciting #MedEd live events at #SABCS25 hosted by @PeerView for CME/MOC/AAPA/NCPD/IPCE credit! Join the #breastcancer experts for insights on approved and emerging therapeutics in #BreastCancer:...
0
5
7
Watch now to get expert insight on the latest evidence of how patients with resectable gastric/GEJ cancer may benefit from neoadjuvant, adjuvant, and perioperative immunotherapies with @YJanjigianMD and Siva Raja, MD, PhD, in #GastricCancer. https://t.co/Geo910boEq
#AATS25
peerview.com
MDADI
0
2
5
Big thanks to @StephenVLiu, @JennyCarlisleMD & @NarjustFlorezMD for leading an insightful discussion at #NACLC25! 💡 Practical insights you can apply in real-world care. 📺 Watch the replay: https://t.co/ci85sCV9sz Grateful to @Amgen, @Genentech & @JazzPharma for supporting
0
8
19
2
6
45
Remember to join us in San Antonio tomorrow at 7:00 PM CST, for our HR+ #BreastCancer live in-person and virtual symposium. @jhaveri_komal @curijoey @elmayermd 🔗 https://t.co/TTOn1KoWIY Please tweet your questions in advance and follow @PeerView for more #MedEd content!
0
4
5
Remember to join us Wednesday, December 10, at 6:30 PM CST, for our HR+, HER2- #BreastCancer live in-person and virtual symposium, produced with @LivingBeyondBC. Please tweet your questions in advance! #MedEd 🔗 https://t.co/X92afavJui
0
5
8